NEXT
Sign in to follow

International Edition

Quartet lead on £136m dental company buyout

Dundas & Wilson, Slaughter and May, Allen & Overy (A&O) and Wragge & Co have advised on the £136m management buyout (MBO) of Associated Dental Practices (ADP). Big four Scots firm Dundas advised ADP chief executive Bharat Patel and management on the MBO, which closed last week (30 November).
1 minute read

International Edition

SJB finance recruit helps to sign off $225m private equity restructuring

SJ Berwin finance partner Ian Borman has completed his first major deal since joining the UK top 20 firm in September from Allen & Overy (A&O), advising private equity firm APEN on its restructuring and $225m (£135m) fund raising. The deal saw ex-A&O partner Borman advising alongside private equity partner Jonathan Pittal for APEN (previously AIG Private Equity) on the deal, which included the restructuring of its private equity fund portfolio and the raising of new finance from Fortress Credit Crop and a Swiss bank.
2 minute read

International Edition

Hammonds wins branding role for Cath Kidston

Hammonds has secured a role acting as sole adviser to luxury retailer Cath Kidston for intellectual property (IP), branding and trademark work. The appointment officially started this month following a competitive tender process. It will see Hammonds' pan-European brands group advising the homeware, fashion and accessory retailer on all IP matters, branding advisory, commercial contract and trademark strategy work.
2 minute read

International Edition

Ashurst and Cleary win lead roles on Rusal's $3bn Hong Kong listing

Cleary Gottlieb Steen & Hamilton and Ashurst have won roles on Rusal's planned $3bn (£2bn) flotation on the Hong Kong stock exchange. Cleary has landed the main role on the listing, fielding a team led by City-based partner Dan Braverman advising on US, English and French law. Ashurst corporate partner Andrew Edge is providing additional English law, while US firm Sidley Austin is advising on Hong Kong law, with a team led by Hong Kong-based capital markets partner Constance Choy.
2 minute read

International Edition

Dealmaker: Sharon Lewis

Lovells capital markets head Sharon Lewis gets in a nod to Hogan and salutes the Pooh school of management
4 minute read

International Edition

Lovells leads for Babcock & Brown on £1bn recapitalisation

Lovells has taken the lead role for Australian group Babcock & Brown Infrastructure (BBI) as it completes a A$1.8bn (£1bn) recapitalisation, signing up Brookfield Asset Management as a new cornerstone investor. Corporate partner Steven Bryan led the team on the deal, which sees Canadian investor Brookfield acquire a 39.9% stake in BBI, as well as certain assets including the UK PD Ports Business.
2 minute read

International Edition

Financial Bill produces more heat on banks but not much light

For all the practical good it will do, it seems that the greatest significance of the new Financial Services Bill is in illustrating the current state of the increasingly ill-tempered policy debate over how to reform and monitor banks. Since the summer there has been growing evidence that banks are driving towards - and increasingly lobbying for - a return to business as usual, while politicians are responding to mounting anger from the public over the excesses of the City.
3 minute read

Legal Week

Financial Bill produces more heat on banks but not much light

For all the practical good it will do, it seems that the greatest significance of the new Financial Services Bill is in illustrating the current state of the increasingly ill-tempered policy debate over how to reform and monitor banks. Since the summer there has been growing evidence that banks are driving towards - and increasingly lobbying for - a return to business as usual, while politicians are responding to mounting anger from the public over the excesses of the City.
8 minute read

International Edition

Dechert leads on $190m rights sale of experimental pain drug

Dechert's London office has won a role advising new client PanGenetics on its $190m (£114m) sale of global rights for an experimental drug to US pharmaceutical company Abbott Laboratories. The US firm has been drafted in to advise antibody engineering company PanGenetics on the sale of a drug used for chronic pain called PG110. The sale will see Abbott acquire the rights to the drug for an upfront payment of $170m (£102m), with additional milestone payments taking the figure to $190m (£114m). The deal equates to selling off part of the company that will house the drug for Abbott.
1 minute read

International Edition

Leading firms act on largest UK pre-pack deal for Wind Hellas

A raft of UK and US firms, including White & Case, Bingham McCutchen, Allen & Overy (A&O) and Slaughter and May, are advising on the UK's largest ever pre-pack administration. Wind Hellas, one of Greece's largest mobile phone operators, filed for administration with the English High Court earlier this month, with parent company Weather Investments set to rescue the business.
2 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • The Role of Evolving Support Structures in Optimizing Legal Talent

    Brought to you by BigHand

    Download Now

  • Corporate Monitorship Advisory Services

    Brought to you by HaystackID

    Download Now

  • AI-Powered Deposition and Medical Record Summaries: Low Risk, High Reward

    Brought to you by Parrot

    Download Now

  • Aligning Client Needs with Lawyer Growth and Profitability

    Brought to you by BigHand

    Download Now